Streetbeat News

Stock Prices

ICCM

RNA

SMX

IceCure Medical announced the release of a study published in 'Cancers' showing the safety and efficacy of ProSense with a 92% disease-free survival rate at a median follow-up of 26.5 months. Avidity Biosciences has partnered with Bristol Myers Squibb in a $2.3 billion deal for cardiovascular RNA therapeutics, receiving $100 million upfront. SMX shares surged 50% premarket after announcing the planned launch of the world's first Plastic Cycle Token.

Portfolio Pulse from ryanfaloona@benzinga.com

November 28, 2023 | 1:45 pm

MODG

PRGO

XRAY

Insider purchases were made in three companies: Perrigo Company plc, DENTSPLY SIRONA Inc., and Topgolf Callaway Brands Corp. Perrigo's EVP and CHRO bought shares after better-than-expected Q3 earnings. DENTSPLY SIRONA's Director made purchases following the announcement of a $1 billion share repurchase program. Topgolf Callaway's President and CEO acquired shares despite mixed Q3 results and lowered FY23 guidance. Insider buying can indicate confidence in the company's prospects or undervaluation.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 1:44 pm

SNES

SenesTech Inc (NASDAQ:SNES) stock plummeted by 36% to $1.18 after announcing a public offering of approximately 3.8 million shares at $1.30 per share, with additional warrants. The offering aims to raise about $5.0 million for general corporate purposes, R&D, and potential acquisitions. The offering is expected to close by November 30, with H.C. Wainwright & Co. as the exclusive placement agent. This follows a brief rise in after-hours trading due to the launch of Evolve Soft Bait at Ace Hardware in California. SNES's 52-week range is $1.75 to $80.98.

Portfolio Pulse from Henry Khederian

November 28, 2023 | 1:43 pm

SNES

SenesTech shares have declined following the announcement of a $5 million public offering. The offering is likely dilutive to existing shareholders, causing the stock price to drop.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:43 pm

NHMD

REBN

The ticker symbol for Reborn Coffee has been corrected to 'REBN'.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:41 pm

META

Meta Platforms, Inc. (META) is facing criticism for its new privacy fee strategy in Europe, where users can either agree to be tracked for personalized advertising or pay up to €251.88 annually for privacy on Instagram and Facebook. Advocacy group NOYB filed a complaint with the Austrian data protection authority, stating the cost is 'unacceptable' and could set a costly trend if other app providers follow suit. A Meta spokesperson defended the pricing, while META shares dropped slightly in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

November 28, 2023 | 1:40 pm

MGRM

Monogram Orthopaedics has achieved a significant revenue milestone by delivering its first surgical robot to a major global distributor. This sale marks the beginning of broader commercialization efforts for the company's robotic technology.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:39 pm

MELI

Susquehanna analyst James Friedman has maintained a Positive rating on MercadoLibre (NASDAQ:MELI) and increased the price target from $1625 to $1850. This adjustment reflects a bullish stance on the company's stock, suggesting potential upside from the current trading levels.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:39 pm

APDN

Applied DNA Sciences, Inc. has received a follow-on order for its Linea DNA product, intended for use in cancer diagnostics, valued above mid-six figures. The company expects to deliver the order during the fiscal quarter ending March 31, 2024, through December 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:35 pm

TM

Toyota Motor Corp (NYSE:TM) and its affiliates are planning to sell approximately 10% of their shares in Denso, an automotive components manufacturer, for an estimated $4.7 billion. This move is part of Toyota's strategy to divest stakes in group companies to fund an increase in electric vehicle (EV) production. Toyota will remain the largest shareholder in Denso post-sale, and Denso may buy back some of its shares to mitigate the impact on its stock price.

Portfolio Pulse from Benzinga Neuro

November 28, 2023 | 1:33 pm